Skip to main content
CHEMCLIN DIAGNOSTICS CO., LTD. logo

CHEMCLIN DIAGNOSTICS CO., LTD. — Investor Relations & Filings

Ticker · 688468 ISIN · CNE100005311 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2024-06-28 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688468

About CHEMCLIN DIAGNOSTICS CO., LTD.

https://www.chemclin.com/

CHEMCLIN DIAGNOSTICS CO., LTD. specializes in the research, development, and manufacturing of in vitro diagnostic systems and reagents. The company is primarily recognized for its proprietary Light-initiated Chemiluminescent Assay (LiCA) technology, a homogeneous chemiluminescence platform that eliminates the need for washing steps, thereby enhancing testing efficiency and precision. Its product portfolio includes fully automated immunoassay analyzers and a comprehensive range of diagnostic kits covering infectious diseases, cardiac markers, thyroid function, tumor markers, and reproductive health. By integrating advanced biotechnology with automated instrumentation, the company provides clinical laboratories and medical institutions with high-sensitivity diagnostic solutions designed to improve patient care and laboratory workflow.

Recent filings

Filing Released Lang Actions
科美诊断技术股份有限公司关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from the company 科美诊断技术股份有限公司 regarding its share repurchase (buyback) program. It details the repurchase plan, progress, amounts, prices, and regulatory compliance. The text includes specific data on shares repurchased, prices, and dates, but it is not a financial report or earnings release. It is a formal disclosure about the company's transaction in its own shares. Therefore, the document fits the category of 'Transaction in Own Shares' (POS). The document length is 1706 characters, which is consistent with a detailed announcement rather than a full report. Hence, the classification is POS with high confidence.
2024-06-28 Chinese
科美诊断技术股份有限公司关于2024年度“提质增效重回报”行动方案的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement from 科美诊断技术股份有限公司 dated June 27, 2024. It outlines the company's 2024 action plan focused on improving quality, efficiency, and shareholder returns, including strategic initiatives, dividend policy, share repurchase updates, governance improvements, risk management, and investor relations. The text is a detailed corporate update rather than a formal financial report or regulatory filing. It does not contain financial statements or quarterly/yearly results, nor is it a notice of voting results or a proxy statement. It is also not a certification or legal proceeding update. The document length is 3227 characters, which is relatively short and reads like a corporate announcement or update. Given the content and format, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous company announcements that do not fit other specific categories.
2024-06-26 Chinese
科美诊断技术股份有限公司关于诉讼进展的公告
Legal Proceedings Report Classification · 95% confidence The document is a detailed announcement regarding a legal proceeding involving the company 科美诊断技术股份有限公司. It describes the litigation stages, parties involved, court rulings, appeals, and the financial impact related to a trademark infringement lawsuit. The text includes references to court decisions, legal claims, and the company's disclosures on the Shanghai Stock Exchange website. There are no financial statements, earnings data, or management discussion of financial results. The content is focused entirely on legal proceedings and their impact on the company. Therefore, this document fits the category of Legal Proceedings Report (LTR). The document length is 3939 characters, which is sufficient for a substantive legal update rather than a brief announcement or certification. Hence, the classification is LTR with high confidence.
2024-06-11 Chinese
中信证券股份有限公司关于科美诊断技术股份有限公司差异化分红事项的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion and verification report from CITIC Securities regarding a differentiated dividend distribution matter for Kemei Diagnostic Technology Co., Ltd. It discusses the legal and regulatory compliance of the dividend distribution, the share repurchase plan, the calculation basis for the dividend, and the company's commitments. The document is not a full financial report but rather a verification or audit opinion related to a specific corporate action (differentiated dividend distribution and share repurchase). It does not contain comprehensive financial statements or management discussion but focuses on compliance and verification. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to specific corporate actions. The document length is 2335 characters, which is short but contains substantive content beyond a mere announcement or certification, so it is not RPA or RNS. Therefore, the best classification is AR with high confidence. FY 2023
2024-06-05 Chinese
科美诊断技术股份有限公司2023年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2023 annual dividend distribution by the company 科美诊断技术股份有限公司. It details the dividend amount per share, relevant dates (record date, ex-dividend date, payment date), the shareholders entitled to the dividend, tax withholding policies, and contact information for inquiries. The document is not a full annual report or financial statement but a specific notice about dividend distribution following the shareholders' meeting approval. It fits the definition of a Notice of Dividend Amount (DIV) as it announces dividend amounts, payment dates, and related details for shareholders. The document length is 3584 characters, which is consistent with a detailed dividend announcement rather than a full report or a brief publication announcement.
2024-06-05 Chinese
科美诊断技术股份有限公司关于诉讼结果的公告
Legal Proceedings Report Classification · 100% confidence The document is a detailed announcement regarding a legal proceeding involving the company as plaintiff in a trademark infringement lawsuit. It includes information about the litigation stage, court rulings, compensation amounts, and the impact on the company. There are no financial statements or financial performance data presented. The document is not a financial report, earnings release, or management discussion. It is clearly a legal proceedings update. Therefore, the appropriate classification is Legal Proceedings Report (LTR). The document length (3615 characters) and content confirm it is a substantive legal update, not a brief announcement or certification.
2024-06-05 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.